Literature DB >> 15825419

Effect of clindamycin on acute and chronic toxoplasmosis in mice.

F G Araujo, J S Remington.   

Abstract

The effect of clindamycin on survival of mice during acute infection with the RH and C56 strains of Toxoplasma and the ability of this drug to prevent congenital transmission during the acute stage of the infection in the mother and to eradicate the parasite from tissues of mice chronically infected with the C56 strain were evaluated. The drug effectively prevented death due to the acute infection and, in the experimental model employed, eradicated the organism at least from the liver, spleen, and brain of approximately 30 to 50% of the acutely infected animals which survived. Clindamycin also effectively prevented congenital transmission during the acute infection in the mother. During short-term treatment (7 days), persistent parasitemia in the chronic infection was effectively diminished or eradicated. More prolonged treatment resulted in a significant clearing of the organisms from the spleens and livers, but not from the brains, of chronically infected mice.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 15825419      PMCID: PMC429028          DOI: 10.1128/AAC.5.6.647

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  TOXOPLASMA AND CHRONIC ABORTION.

Authors:  J S REMINGTON
Journal:  Obstet Gynecol       Date:  1964-07       Impact factor: 7.661

2.  TOXOPLASMA PARASITES IN DIFFERENT ORGANS OF MICE AND HAMSTERS INFECTED WITH AVIRULENT AND VIRULENT STRAINS.

Authors:  H DE ROEVER-BONNET
Journal:  Trop Geogr Med       Date:  1964-12

3.  [Spiramycin therapy of experimental toxoplasmosis in mice].

Authors:  J P GARIN; D E EYLES
Journal:  Presse Med       Date:  1958-05-28       Impact factor: 1.228

4.  Ocular toxoplasmosis; pathogenesis, diagnosis and treatment.

Authors:  J K FRENKEL; L JACOBS
Journal:  AMA Arch Ophthalmol       Date:  1958-02

5.  Serological study of toxoplasmosis prevalence.

Authors:  H A FELDMAN; L T MILLER
Journal:  Am J Hyg       Date:  1956-11

Review 6.  Toxoplasmosis in the adult.

Authors:  J S Remington
Journal:  Bull N Y Acad Med       Date:  1974-02

7.  The effect of two chlorinated lincomycin analogues against acute toxoplasmosis in mice.

Authors:  P R McMaster; K G Powers; J F Finerty; M N Lunde
Journal:  Am J Trop Med Hyg       Date:  1973-01       Impact factor: 2.345

8.  Studies on toxoplasmosis in El Salvador. Prevalence and incidence of toxoplasmosis as measured by the Sabin-Feldman dye test.

Authors:  J S Remington; B Efron; E Cavanaugh; H J Simon; A Trejos
Journal:  Trans R Soc Trop Med Hyg       Date:  1970       Impact factor: 2.184

9.  The effect of rifampin on Toxoplasma gondii.

Authors:  J S Remington; T Yagura; W S Robinson
Journal:  Proc Soc Exp Biol Med       Date:  1970-10

10.  Penetration of cephalothin and lincomycin into the cerebrospinal fluid.

Authors:  P I Lerner
Journal:  Am J Med Sci       Date:  1969-02       Impact factor: 2.378

View more
  33 in total

1.  Evaluation of the efficacy and safety of clindamycin plus pyrimethamine for induction and maintenance therapy of toxoplasmic encephalitis in AIDS.

Authors:  C Katlama
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-03       Impact factor: 3.267

2.  Efficacy of clindamycin/primaquine versus trimethoprim/sulfamethoxazole in primary treatment of Pneumocystis carinii pneumonia.

Authors:  B Ruf; I Rohde; H D Pohle
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-03       Impact factor: 3.267

3.  Clinical programs for clinical research on AIDS: description of a randomized prospective study of clindamycin versus pyrimethamine for prevention of Toxoplasma gondii infection.

Authors:  M A Jacobson; C L Besch; C Child; R Hafner; K Muth; L Deyton
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-03       Impact factor: 3.267

4.  Effect of clindamycin on intracellular replication, protein synthesis, and infectivity of Toxoplasma gondii.

Authors:  J Blais; C Tardif; S Chamberland
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

5.  Paradoxical effect of clindamycin in experimental, acute toxoplasmosis in cats.

Authors:  M G Davidson; M R Lappin; J R Rottman; M B Tompkins; R V English; A T Bruce; J Jayawickrama
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

Review 6.  Toxoplasma gondii and schizophrenia: a review of published RCTs.

Authors:  Sam D Chorlton
Journal:  Parasitol Res       Date:  2017-05-15       Impact factor: 2.289

7.  Activity of gamma interferon in combination with pyrimethamine or clindamycin in treatment of murine toxoplasmosis.

Authors:  D Israelski; J Remington
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-05       Impact factor: 3.267

8.  New micromethod to study the effect of antimicrobial agents on Toxoplasma gondii: comparison of sulfadoxine and sulfadiazine individually and in combination with pyrimethamine and study of clindamycin, metronidazole, and cyclosporin A.

Authors:  D G Mack; R McLeod
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

9.  In vitro and in vivo effects of doxycycline on Toxoplasma gondii.

Authors:  H R Chang; R Comte; J C Pechère
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

10.  Trovafloxacin is active against Toxoplasma gondii.

Authors:  A A Khan; T Slifer; F G Araujo; J S Remington
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.